News|Articles|September 23, 2024
Nitrosamines, Meeting Regulatory Requirements
Author(s)Phenomenex, Inc.
The necessity to analyse drug products for nitrosamines and NDSRIs (Nitrosamine Drug Substance Related Impurities) is well documented. In this document we provide an overview of 7 of our most recent applications in this area, together with links to the relevant technical notes.
Related Content
Trending on LCGC International
1
HPLC, PTR-ToF-MS Enable AI Grading of White Tea
2
LC-MS/MS Links Vitamin D Levels to Sleep Timing
3
LC-MS/MS Finds PFAS Migration from Stuffed Toys
4
How Should You Respond to FDA 483 Observations?
5